CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$2.83
Tradestie Score
47
Market Cap
$330.07M
Revenue Growth
-0.4%
Analyst Upside
+168.7%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.46
|
$308.74M | - | 54 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.84
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$18.81
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$27.76
|
$293.03M | - | 51 | Compare |
|
OMER
Omeros Corporation
|
$12.32
|
$281.75M | 10.2 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.41
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.82
|
$275.13M | - | 50 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$21.01
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.47
|
$262.67M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
More CLLS Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry